From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Back

Decision Making in Gender Affirming Contraception: Consultation Essentials

First published:

November 2025

Last published:

November 2025

Overview

The Decision Making in Gender Affirming Contraception: Consultation Essentials resource is a valuable tool designed to support clinicians to conduct gender affirming contraceptive consultations. Based on ASHM’s Decision Making in Contraception Tool this quick reference resource addresses the specific contraceptive needs of trans and gender diverse people, particularly those on hormone therapy. 

This resource features a quick reference table which summarises the advantages and disadvantages of different contraceptive options. This table serves as a valuable tool to facilitate meaningful discussions with patients, enabling clinicians to explore the pros and cons of each method and guide individuals towards informed decision-making.

By utilising the Decision Making in Gender Affirming Contraception resource, clinicians can enhance their ability to provide inclusive, evidence-based contraceptive care to trans and gender diverse people. 

This resource was developed in partnership with ACON, AusPATH, Children by Choice, and the Pharmaceutical Society of Australia.

The Decision Making in Gender Affirming Contraception: Consultation Essentials resource is supported by funding from the Australian Government Department of Health, Disability, and Ageing under the Quality Use of Diagnostics, Therapeutics, and Pathology program.